Holen Sie sich die Stockscreener-App
80.02
0.51%
-0.3961
Schlusskurs vom Vortag:
$80.42
Offen:
$80.51
24-Stunden-Volumen:
486.93K
Relative Volume:
0.50
Marktkapitalisierung:
$5.17B
Einnahmen:
$1.54B
Nettoeinkommen (Verlust:
$233.56M
KGV:
23.77
EPS:
3.3669
Netto-Cashflow:
$348.64M
1W Leistung:
+10.27%
1M Leistung:
+15.32%
6M Leistung:
+51.13%
1J Leistung:
-19.42%
1-Tages-Spanne:
$78.62
$81.44
1-Wochen-Bereich:
$72.34
$84.38
52-Wochen-Spanne:
$47.25
$108.91
Lantheus Holdings Inc Stock (LNTH) Company Profile
Firmenname
Lantheus Holdings Inc
Sektor
Telefon
978 671-8001
Adresse
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
80.01 | 5.20B | 1.54B | 233.56M | 348.64M | 3.3669 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.79 | 56.14B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.14 | 48.74B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.04 | 44.85B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.64 | 34.12B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
537.64 | 23.35B | 3.13B | 1.27B | 1.12B | 26.39 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-12-12 | Hochstufung | Truist | Hold → Buy |
| 2025-10-08 | Herabstufung | Goldman | Buy → Neutral |
| 2025-08-12 | Herabstufung | Truist | Buy → Hold |
| 2024-12-18 | Eingeleitet | Goldman | Buy |
| 2024-09-03 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-07-10 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-12-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Eingeleitet | TD Cowen | Outperform |
| 2023-09-29 | Eingeleitet | William Blair | Outperform |
| 2023-03-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-11-30 | Eingeleitet | SVB Leerink | Outperform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-05-09 | Eingeleitet | B. Riley Securities | Buy |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2021-02-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-29 | Fortgesetzt | Jefferies | Buy |
| 2019-08-16 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-09-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2016-02-24 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-12-11 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Eingeleitet | Credit Suisse | Outperform |
| 2015-07-20 | Eingeleitet | Jefferies | Buy |
| 2015-07-20 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-07-20 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-20 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten
Lantheus Holdings (LNTH) Is Up 5.4% After New PYLARIFY TruVu And LUTATHERA ApprovalsHas The Bull Case Changed? - simplywall.st
Why Lantheus (LNTH) Is Up 5.4% After Dual FDA Wins In Radiopharmaceutical Oncology Expansion - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Stockholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Lantheus Stock Analysis: 57% Gain Amid Revenue and Margin ConcernsNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - Yahoo Finance UK
WINTON GROUP Ltd Grows Position in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus at Leerink Conference: Strategic Shifts and Challenges - Investing.com Nigeria
Why Lantheus Holdings stock popped by almost 12% last month - MSN
Why Lantheus Holdings Stock Popped by Almost 12% Last Month - AOL.com
Lantheus Holdings Inc (LNTH) Stock Price Up 7.21% on Mar 9 - GuruFocus
Lantheus (NASDAQ:LNTH) Trading 7.2% HigherTime to Buy? - MarketBeat
Citizens reiterates Lantheus stock rating on royalty opportunities By Investing.com - Investing.com Canada
Why Is LNTH Stock Up After Hours? - Stocktwits
(LNTH) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Reach Out - ACCESS Newswire
2026-03-08 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Reach Out | NDAQ:LNTH | Press Release - Stockhouse
FDA approves Lantheus’ PYLARIFY TruVu for prostate cancer imaging By Investing.com - Investing.com Australia
FDA approves Lantheus’ PYLARIFY TruVu for prostate cancer imaging - Investing.com Nigeria
Teachers Retirement System of The State of Kentucky Reduces Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat
Wall Street Zen Upgrades Lantheus (NASDAQ:LNTH) to Strong-Buy - MarketBeat
American Century Companies Inc. Sells 341,642 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection - Sahm
TD Cowen updates financial model citing upcoming Q4 results for Lantheus Holdings, Inc. (LNTH) - MSN
Lantheus (LNTH) Gains FDA Approval for New Prostate Cancer Imagi - GuruFocus
Lantheus Announces FDA Approval of PYLARIFY TruVu (piflufolastat F 18) Injection - Finviz
Lantheus Announces FDA Approval of PYLARIFY TruVu™, a New Formulation of Its PSMA PET Imaging Agent to Enhance Patient Access and Supply Capacity - Quiver Quantitative
Lantheus announces FDA approval of Pylarify TruVu (piflufolastat F 18) injection - marketscreener.com
US FDA approves Lantheus' new prostate cancer imaging formulation - Reuters
FDA OKs new PYLARIFY TruVu scan to expand prostate cancer imaging - Stock Titan
Heron Bay Capital Management Acquires New Shares in Lantheus Holdings, Inc. $LNTH - MarketBeat
Elo Mutual Pension Insurance Co Acquires New Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus Bets On TruVu To Keep PYLARIFY Growing - Finimize
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Stockholders to Reach Out - ACCESS Newswire
Quantbot Technologies LP Makes New Investment in Lantheus Holdings, Inc. $LNTH - MarketBeat
Equity award, tax share disposition for Lantheus (LNTH) officer - Stock Titan
Lantheus (NASDAQ: LNTH) CCO logs PSU vesting, tax withholding - Stock Titan
Lantheus Holdings (LNTH) CFO nets PSU award, withholds shares for taxes - Stock Titan
LNTH Stock Price, Quote & Chart | LANTHEUS HOLDINGS INC (NASDAQ:LNTH) - ChartMill
William Blair Investment Management LLC Has $29.48 Million Stake in Lantheus Holdings, Inc. $LNTH - MarketBeat
Intech Investment Management LLC Sells 33,704 Shares of Lantheus Holdings, Inc. $LNTH - MarketBeat
Lantheus receives FDA tentative approval for generic cancer drug By Investing.com - Investing.com Canada
Lantheus Holdings (LNTH): Analyst Raises Price Target to $89 | L - GuruFocus
Lantheus (LNTH) Secures FDA Tentative Nod for New Cancer Treatme - GuruFocus
Lantheus Says US FDA Tentatively Approves PNT2003 - marketscreener.com
Lantheus receives FDA tentative approval for generic cancer drug - Investing.com India
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA® - The Manila Times
Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Innovator with a 21% Upside Potential - DirectorsTalk Interviews
Assessing Lantheus Holdings (LNTH) Valuation After Recent Share Price Rebound And PYLARIFY Outlook - Yahoo Finance
Lantheus Holdings, Inc. $LNTH Shares Sold by Artisan Partners Limited Partnership - MarketBeat
Lantheus Holdings (LNTH) Net Margin Decline Tests Bullish Earnings Growth Narrative - Sahm
Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
1.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):